These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Comparison of Unterrainer M; Fleischmann DF; Diekmann C; Vomacka L; Lindner S; Vettermann F; Brendel M; Wenter V; Ertl-Wagner B; Herms J; Wetzel C; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):580-590. PubMed ID: 30244386 [TBL] [Abstract][Full Text] [Related]
12. Heterogeneous parameters based on Hua T; Zhou W; Zhou Z; Guan Y; Li M Quant Imaging Med Surg; 2021 Jan; 11(1):317-327. PubMed ID: 33392031 [TBL] [Abstract][Full Text] [Related]
13. Predicting IDH genotype in gliomas using FET PET radiomics. Lohmann P; Lerche C; Bauer EK; Steger J; Stoffels G; Blau T; Dunkl V; Kocher M; Viswanathan S; Filss CP; Stegmayr C; Ruge MI; Neumaier B; Shah NJ; Fink GR; Langen KJ; Galldiks N Sci Rep; 2018 Sep; 8(1):13328. PubMed ID: 30190592 [TBL] [Abstract][Full Text] [Related]
14. Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[ Bauer EK; Stoffels G; Blau T; Reifenberger G; Felsberg J; Werner JM; Lohmann P; Rosen J; Ceccon G; Tscherpel C; Rapp M; Sabel M; Filss CP; Shah NJ; Neumaier B; Fink GR; Langen KJ; Galldiks N Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1486-1495. PubMed ID: 32034446 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement. Rosen J; Stoffels G; Lohmann P; Bauer EK; Werner JM; Wollring M; Rapp M; Felsberg J; Kocher M; Fink GR; Langen KJ; Galldiks N Sci Rep; 2021 Oct; 11(1):20828. PubMed ID: 34675225 [TBL] [Abstract][Full Text] [Related]
17. The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers. Skoblar Vidmar M; Doma A; Smrdel U; Zevnik K; Studen A Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743228 [TBL] [Abstract][Full Text] [Related]
18. Integrated CT Radiomics Features Could Enhance the Efficacy of Zhou W; Huang Q; Wen J; Li M; Zhu Y; Liu Y; Dai Y; Guan Y; Zhou Z; Hua T Front Oncol; 2021; 11():772703. PubMed ID: 34869011 [TBL] [Abstract][Full Text] [Related]
19. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [(18)F]FET-PET imaging in intracranial WHO grade II and III gliomas. Jansen NL; Schwartz C; Graute V; Eigenbrod S; Lutz J; Egensperger R; Pöpperl G; Kretzschmar HA; Cumming P; Bartenstein P; Tonn JC; Kreth FW; la Fougère C; Thon N Neuro Oncol; 2012 Dec; 14(12):1473-80. PubMed ID: 23090986 [TBL] [Abstract][Full Text] [Related]
20. Textural analysis of pre-therapeutic [18F]-FET-PET and its correlation with tumor grade and patient survival in high-grade gliomas. Pyka T; Gempt J; Hiob D; Ringel F; Schlegel J; Bette S; Wester HJ; Meyer B; Förster S Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):133-141. PubMed ID: 26219871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]